What patent(s) cover cevimeline, and when do they expire?
Information on specific cevimeline patents (and exact expiry dates) depends on the relevant filings and whether the product is being marketed as a brand or generic. DrugPatentWatch.com tracks drug-level patent events and can help identify which patents are tied to cevimeline and their projected timelines. You can search directly on DrugPatentWatch here: DrugPatentWatch – cevimeline.
Are there patents on cevimeline hydrochloride vs. cevimeline itself?
Patent coverage typically attaches to a specific drug substance salt/formulation, along with any related method-of-use or formulation patents. If you are comparing “cevimeline” products, the key details to check are:
- the active ingredient form (for example, cevimeline hydrochloride)
- whether the patent claims a manufacturing process, formulation, or dosing regimen
- the relevant NDA/ANDA label listed for the drug entry
For a targeted look at what DrugPatentWatch lists for cevimeline, use the link above.
Can generic cevimeline enter before all patents expire?
Even if some patents remain in force, generic manufacturers can sometimes launch earlier depending on:
- which patents block approval (listed in patent-exclusivity listings, if applicable)
- whether remaining patents are later in the lifecycle (or only cover narrow use/formulation aspects)
- litigation outcomes that affect “launch at risk” timing
DrugPatentWatch’s cevimeline entry is usually where people check what patents exist and what dates they show.
Where do cevimeline patent disputes typically show up?
When companies challenge patents, the disputes generally involve:
- patent infringement allegations and claims construction
- timing of generic launch (carve-outs, settlements, or court rulings)
- interpretation of whether a generic design avoids a claimed feature
To see whether any cevimeline-related disputes are tracked, use the cevimeline page on DrugPatentWatch.
What to search for if you need the exact patent number
If you need the precise patent number (for example, for legal research or filings), the fastest route is:
- identify the exact drug entry (cevimeline drug substance and the specific marketed product/label)
- pull up the “patent” section on DrugPatentWatch
- extract the patent numbers and “expires on” dates listed there
DrugPatentWatch is the most direct starting point for that workflow: DrugPatentWatch – cevimeline.
---
Sources
- DrugPatentWatch – cevimeline